Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
IMUX similar filings
- 18 Feb 21 Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial
- 4 Jan 21 Entry into a Material Definitive Agreement
- 13 Nov 20 Entry into a Material Definitive Agreement
- 5 Nov 20 Immunic, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update
- 20 Oct 20 EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
- 11 Sep 20 Regulation FD Disclosure
- 10 Aug 20 Entry into a Material Definitive Agreement
Filing view
External links